Article(id=1326652641838477364, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.06.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1737993600000, receivedDateStr=2025-01-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228237828, onlineDateStr=2026-11-09, pubDate=1749484800000, pubDateStr=2025-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228237828, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228237828, creator=13701087609, updateTime=1794228237828, updator=13701087609, issue=Issue{id=1326652618341987109, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='6', pageStart='529', pageEnd='636', issueExtLink='null', onlineDate='null', pubDate='1749484800000', pubDateStr='2025-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228232226, creator='13701087609', updateTime=1794273016466, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326840457423860645, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326840457423860646, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326652618341987109, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=534, endPage=540, ext={EN=ArticleExt(id=1326652642064969781, articleId=1326652641838477364, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Advances in drug therapy for systemic lupus erythematosus, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Systemic lupus erythematosus(SLE) is is a chronic autoimmune disease characterized by multi-system involvement. The disease recurs repeatedly, often accompanied by infections and organ damage, which seriously threaten the quality of life of patients. With the breakthroughs of molecular immunology research, important progress has been made in the targeted treatment strategies for SLE. Based on evidence-based medical evidence, this paper systematically reviewed current drug treatment regimens for SLE, mainly including the optimized application of traditional drugs, as well as the clinical value of innovative therapies such as biological agents like belimumab and telitacicept, and novel treatment approaches such as chimeric antigen receptor T-cell immunotherapy, in order to provide evidence-based basis for individualized treatment decisions.

, authors=Xinyue XIE1, Guangtao XIA2, Wubin LIU1, *, authorsList=Xinyue XIE, Guangtao XIA, Wubin LIU, authorCompany=null, correspAuthors=Wubin LIU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326652642375348278, articleId=1326652641838477364, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=系统性红斑狼疮药物治疗进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

系统性红斑狼疮(systemic lupus erythematosus,SLE)是一种以多系统受累为特征的慢性自身免疫性疾病,病情反复发作,常伴随感染及器官损伤,威胁患者生存质量。随着分子免疫学研究的突破,SLE的靶向治疗策略取得重要进展。文章基于循证医学证据,系统综述当前SLE药物治疗方案,主要包括传统药物的优化应用,以及创新疗法如贝利尤单抗(belimumab)、泰它西普(telitacicept)等生物制剂和嵌合抗原受体T细胞免疫疗法等新型治疗手段的临床价值,以期为个体化治疗决策提供循证依据。

, authors=谢昕悦1, 夏光涛2, 刘务斌1, *, authorsList=谢昕悦, 夏光涛, 刘务斌, authorCompany=null, correspAuthors=刘务斌, authorNote=

谢昕悦,主治医师,研究方向:风湿免疫疾病诊治。

, correspAuthorsNote=
刘务斌,主治医师,研究方向:风湿免疫疾病诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=aVD4sHKQGEPRqPh7xHAKfw==, magXml=tUo8MSfuSkxggKb5D9fwXg==, pdfUrl=null, pdf=7L4OSS8xi7wKtVDptTlxug==, pdfFileSize=959630, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=KuTJM6EFLMHAvksOb4x7Qw==, mapNumber=null, fund=null)}, authors=[Author(id=1326652644522831934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652644615106624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652644522831934, language=EN, stringName=Xinyue XIE, firstName=Xinyue, middleName=null, lastName=XIE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652644690604097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652644522831934, language=CN, stringName=谢昕悦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.济南市市中区人民医院内科,山东 济南 250000, bio={"content":"

谢昕悦,主治医师,研究方向:风湿免疫疾病诊治。

"}, bioImg=null, bioContent=

谢昕悦,主治医师,研究方向:风湿免疫疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652642765418551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, xref=1., ext=[AuthorCompanyExt(id=1326652642773807160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China), AuthorCompanyExt(id=1326652642786390073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.济南市市中区人民医院内科,山东 济南 250000)])]), Author(id=1326652644833210435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652644921290821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652644833210435, language=EN, stringName=Guangtao XIA, firstName=Guangtao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652644984205382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652644833210435, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652644426362938, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, xref=2., ext=[AuthorCompanyExt(id=1326652644434751547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652644426362938, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1326652644443140156, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652644426362938, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])]), Author(id=1326652645051314248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652645118423114, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652645051314248, language=EN, stringName=Wubin LIU, firstName=Wubin, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652645185531979, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652645051314248, language=CN, stringName=刘务斌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.济南市市中区人民医院内科,山东 济南 250000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652642765418551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, xref=1., ext=[AuthorCompanyExt(id=1326652642773807160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China), AuthorCompanyExt(id=1326652642786390073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.济南市市中区人民医院内科,山东 济南 250000)])])], keywords=[Keyword(id=1326652645273612364, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, language=EN, orderNo=1, keyword=systemic lupus erythematosus), Keyword(id=1326652645344915533, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, language=EN, orderNo=2, keyword=drug treatment), Keyword(id=1326652645399441486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, language=EN, orderNo=3, keyword=targeted therapy), Keyword(id=1326652645470744655, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, language=CN, orderNo=1, keyword=系统性红斑狼疮), Keyword(id=1326652645533659216, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, language=CN, orderNo=2, keyword=药物治疗), Keyword(id=1326652645604962385, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, language=CN, orderNo=3, keyword=靶向治疗)], refs=[Reference(id=1326652645835649107, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=葛均波, 王辰, 王建安. 内科学[M]. 第10版. 北京: 人民卫生出版社, 2024: 820-826., articleTitle=null, refAbstract=null), Reference(id=1326652645995032660, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=梅杨. RSAD2在SLE患者B细胞中异常表达及功能研究[D]. 长沙: 中南大学, 2023., articleTitle=null, refAbstract=null), Reference(id=1326652646146027605, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=尚双双, 李明, 黄传兵. lncRNAs在系统性红斑狼疮中的研究进展[J]. 中国免疫学杂志, 2023, 39(12): 2662-2665., articleTitle=null, refAbstract=null), Reference(id=1326652646217330774, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=苗林, 王清翠, 陈晓华. 组蛋白修饰在系统性红斑狼疮发病机制中作用的研究进展[J]. 中国医药导报, 2023, 20(30):68-71., articleTitle=null, refAbstract=null), Reference(id=1326652646297022551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=韦安吉, 王春芳. m6 A修饰与调节免疫在系统性红斑狼疮的研究进展[J]. 右江医学, 2023, 51(6): 486-491., articleTitle=null, refAbstract=null), Reference(id=1326652646355742808, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=夏源, 李向培. 微小RNA调控干扰素-α在系统性红斑狼疮发病机制中的作用[J]. 协和医学杂志, 2019, 10(6): 673-678., articleTitle=null, refAbstract=null), Reference(id=1326652646418657369, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=KIRIAKIDOU M, CHING CL. Systemic lupus erythematosus[J]. Ann Intern Med, 2020, 172(11): ITC81-ITC96., articleTitle=null, refAbstract=null), Reference(id=1326652646502543451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=董霞. 调节性B细胞在自身免疫性皮肤病中的研究进展[J].中国城乡企业卫生, 2024, 39(3): 22-24., articleTitle=null, refAbstract=null), Reference(id=1326652646569652316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=崔峥, 李鸿斌. 靶向B细胞治疗系统性红斑狼疮研究进展[J]. 内蒙古医科大学学报, 2023, 45(3): 324-328., articleTitle=null, refAbstract=null), Reference(id=1326652646624178269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3):172-185., articleTitle=null, refAbstract=null), Reference(id=1326652646691287134, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=张昕, 赵盛楠, 冯学兵. 中国系统性红斑狼疮的诊治现状及挑战[J]. 诊断学理论与实践, 2024, 23(3): 257-262., articleTitle=null, refAbstract=null), Reference(id=1326652646779367519, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=季兰岚, 张卓莉. 欧洲抗风湿联盟发布系统性红斑狼疮新的管理指南[J]. 中华风湿病学杂志, 2020, 24(7): 500-502., articleTitle=null, refAbstract=null), Reference(id=1326652646854864992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=黄玉琼, 张亚敏, 陶娟. 糖皮质激素在系统性红斑狼疮中的应用及研究现状[J]. 皮肤科学通报, 2018, 35(3): 296-304., articleTitle=null, refAbstract=null), Reference(id=1326652646917779553, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=王钢. 系统性红斑狼疮长期糖皮质激素维持治疗与器官累积损伤的相关性研究[D]. 合肥: 安徽医科大学, 2017., articleTitle=null, refAbstract=null), Reference(id=1326652646980694114, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=DENG J, CHALHOUB NE, SHERWIN CM, et al.Glucocorticoids pharmacology and their application in the treatment of childhoodonset systemic lupus erythematosus[J].Semin Arthritis Rheum, 2019, 49(2): 251-259., articleTitle=null, refAbstract=null), Reference(id=1326652647039414371, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=柴富, 王春芳. 系统性红斑狼疮相关药物治疗的研究进展[J]. 检验医学与临床, 2022, 19(10): 1423-1427., articleTitle=null, refAbstract=null), Reference(id=1326652647106523236, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=胡曦丹, 王卓. 选择性环氧合酶-2(COX-2)非甾体抗炎药的安全性与有效性[J]. 药学服务与研究, 2016, 16(2): 81-85., articleTitle=null, refAbstract=null), Reference(id=1326652647186215013, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=BINDU S, MAZUMDER S, BANDYOPADHYAY U. Non-steroidal anti-inflammatory drugs(NSAIDs) and organ damage: a current perspective[J]. Biochem Pharmacol, 2020:114147., articleTitle=null, refAbstract=null), Reference(id=1326652648872325223, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=李德鑫, 程振田, 马玉奎. 系统性红斑狼疮治疗药物研究进展[J]. 食品与药品, 2024, 26(4): 405-410., articleTitle=null, refAbstract=null), Reference(id=1326652648943628392, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=王玲玲. 吗替麦考酚酯治疗难治性狼疮性肾炎的临床疗效观察[J]. 航空航天医学杂志, 2022, 33(6): 709-711., articleTitle=null, refAbstract=null), Reference(id=1326652649086234729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=库丽. 吗替麦考酚酯联合甲泼尼龙对狼疮肾炎患者系统性红斑狼疮疾病活动指数评分及免疫指标的影响[J].山西医药杂志, 2021, 50(7): 1121-1123., articleTitle=null, refAbstract=null), Reference(id=1326652649216258154, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=韩洋, 费文敏, 李可可, 等. 免疫抑制剂的概念和类型[J].皮肤科学通报, 2021, 38(4): 291-297., articleTitle=null, refAbstract=null), Reference(id=1326652649304338539, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=苏利沙, 张根豪, 邓少丽, 等. 常用免疫抑制剂治疗对系统性红斑狼疮患者淋巴细胞亚群的影响[J]. 郑州大学学报(医学版), 2014, 49(2): 236-239., articleTitle=null, refAbstract=null), Reference(id=1326652649388224620, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=王鑫梅, 谢菡. 羟氯喹治疗系统性红斑狼疮的作用机制及疗效研究进展[J]. 山东医药, 2024, 64(26): 111-115., articleTitle=null, refAbstract=null), Reference(id=1326652649484693613, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=GORDON C, AMISSAH-ARTHUR MB, GAYED M, et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults[J].Rheumatology(Oxford), 2018, 57(1): e1-e45., articleTitle=null, refAbstract=null), Reference(id=1326652649547608174, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=FANOURIAKIS A, KOSTOPOULOU M, ANDERSEN J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update[J]. Ann Rheum Dis, 2024, 83(10): e19., articleTitle=null, refAbstract=null), Reference(id=1326652649618911343, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=钟永芳. 羟氯喹对系统性红斑狼疮患者黄斑区视网膜和脉络膜厚度的影响[D]. 承德: 承德医学院, 2024., articleTitle=null, refAbstract=null), Reference(id=1326652649690214512, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHENG J, GU J, SU Y, et al. Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: results of exploratory subgroup analyses[J]. Mod Rheumato, 202, 33(4): 751-757., articleTitle=null, refAbstract=null), Reference(id=1326652649765711985, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=许蕾, 朱芸, 张昊. 贝利尤单抗治疗系统性红斑狼疮的短期临床观察[J]. 中国医药导报, 2021, 18(31): 96-99., articleTitle=null, refAbstract=null), Reference(id=1326652649857986674, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=郭孟, 陈小三, 蒋玲, 等. 贝利尤单抗对系统性红斑狼疮患者自身抗体浓度的影响[J]. 江苏医药, 2023, 49(3): 300-302., articleTitle=null, refAbstract=null), Reference(id=1326652649933484147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=唐鹏芳. 贝利尤单抗在系统性红斑狼疮中的疗效及对淋巴细胞VCS参数的影响[J]. 中国医学创新, 2023, 20(11): 10-13., articleTitle=null, refAbstract=null), Reference(id=1326652650004787316, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=张洁. 贝利尤单抗在系统性红斑狼疮患者中的应用效果观察[J]. 实用中西医结合临床, 2024, 24(12): 71-74., articleTitle=null, refAbstract=null), Reference(id=1326652650067701877, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=董瑶. 贝利尤单抗联合羟氯喹与泼尼松治疗系统性红斑狼疮患者的效果[J]. 中国民康医学, 2024, 36(15): 48-51., articleTitle=null, refAbstract=null), Reference(id=1326652650139005046, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=丁琳. 贝利尤单抗治疗难治性狼疮性肾炎的疗效观察及安全性评估[D]. 济南: 山东大学, 2023., articleTitle=null, refAbstract=null), Reference(id=1326652650206113911, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=邹婵娟, 丁菱, 王敏, 等. 贝利尤单抗治疗系统性红斑狼疮合并血栓性微血管病1例并文献复习[J]. 中国医学前沿杂志(电子版), 2023, 15(11): 71-78., articleTitle=null, refAbstract=null), Reference(id=1326652650281611384, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=杨佳, 高洁, 赵文静, 等. 泰它西普在IgA肾病和狼疮性肾炎中的研究进展[J]. 中国现代医学杂志, 2022, 32(19): 51-56., articleTitle=null, refAbstract=null), Reference(id=1326652650348720249, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=SHI F, XUE R, ZHOU X, et al. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease[J]. Immunopharmacol Immunotoxicol, 2021, 43(6): 666-673., articleTitle=null, refAbstract=null), Reference(id=1326652650449383546, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=江文静, 何德宁, 胡建康, 等. 泰它西普治疗中重度活动性系统性红斑狼疮的疗效及全安性观察[J]. 江西医药, 2020,55(11): 1637-1641., articleTitle=null, refAbstract=null), Reference(id=1326652650524881019, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=林千祺, 许夏雨, 邢诒喜, 等. 泰它西普联合标准方案治疗Ⅲ-Ⅴ型活动性狼疮肾炎临床观察[J]. 中国药业, 2023,32(12): 97-100., articleTitle=null, refAbstract=null), Reference(id=1326652650591989884, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=万雨涵, 杨定平. 难治性狼疮性肾炎的治疗方法应用进展[J]. 山东医药, 2024, 64(14): 90-94., articleTitle=null, refAbstract=null), Reference(id=1326652650667487357, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=李浩, 李江涛, 刘丹, 等. 贝利尤单抗和阿尼鲁单抗及泰它西普治疗系统性红斑狼疮疗效和安全性的网状Meta分析[J]. 中国全科医学, 2024: 1-11., articleTitle=null, refAbstract=null), Reference(id=1326652650730401918, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=CROW MK. Type Ⅰ interferon in the pathogenesis of lupus[J]. Ann Rheum Dis, 2023, 82(8): 999-1014., articleTitle=null, refAbstract=null), Reference(id=1326652650801705087, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=RIGGS JM, HANNA RN, RAJAN B, et al. Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist anti body for the treatment of systemic lupus erythematosus[J]. Lupus Sci Med, 2018, 5(1): e000261., articleTitle=null, refAbstract=null), Reference(id=1326652650860425344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=张培. 注射用贝利尤单抗和阿尼鲁单抗治疗系统性红斑狼疮疗效和安全性的网状meta分析[D]. 石家庄: 河北医科大学, 2023., articleTitle=null, refAbstract=null), Reference(id=1326652650940117121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=MORAND EF, FURIE R, TANAKA Y, et al. Trial of anifrolumab in active systemic lupus erythematosus[J]. N Engl J Med, 2020, 382(3): 211-221., articleTitle=null, refAbstract=null), Reference(id=1326652651024003202, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=陈晓梅, 吴雪, 罗采南, 等. 系统性红斑狼疮的靶向治疗药物研究进展[J]. 中国新药杂志, 2022, 31(23): 2310-2317., articleTitle=null, refAbstract=null), Reference(id=1326652651124666499, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=张幸国, 林能明, 赵青威, 等. 利妥昔单抗超说明书用药专家共识[J]. 中国现代应用药学, 2024, 41(16): 2298-2310., articleTitle=null, refAbstract=null), Reference(id=1326652651204358276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=石祥东. 评价小剂量利妥昔单抗治疗系统性红斑狼疮(SLE)的疗效和安全性[J]. 世界复合医学, 2021, 7(1):169-171., articleTitle=null, refAbstract=null), Reference(id=1326652651271467141, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=张玲玲, 魏伟. 治疗自身免疫病药物研究进展[J]. 中国药理学通报, 2019, 35(2): 149-156., articleTitle=null, refAbstract=null), Reference(id=1326652651359547526, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=FANOURIAKIS A, KOSTOPOULOU M, ALUNNO A,et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(6): 736-745., articleTitle=null, refAbstract=null), Reference(id=1326652651456016519, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=龙博泉, 杨岚, 马萍萍, 等. 利妥昔单抗治疗系统性红斑狼疮伴血液危象一例[J]. 中国麻风皮肤病杂志, 2023,39(12): 898-900., articleTitle=null, refAbstract=null), Reference(id=1326652651531513992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=MOUGIAKAKOS D, KRONKE G, VOLKL S, et al.CD19-targeted CAR T cells in refractory systemic lupus erythematosus[J]. N Engl J Med, 2021, 385(6): 567-569., articleTitle=null, refAbstract=null), Reference(id=1326652651602817161, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=MACKENSEN A, MULLER F, MOUGIAKAKOS D, et al.Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus[J]. Nat Med, 2022, 28(10): 2124-2132., articleTitle=null, refAbstract=null), Reference(id=1326652651674120330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=MULLER F, TAUBMANN J, BUCCI L, et al. CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up[J]. N Engl J Med, 2024, 390(8): 687-700., articleTitle=null, refAbstract=null)], funds=[Fund(id=1326652645722402898, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, awardId=ZR2021MH265, language=CN, fundingSource=山东省自然科学基金(ZR2021MH265), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1326652642765418551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, xref=1., ext=[AuthorCompanyExt(id=1326652642773807160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China), AuthorCompanyExt(id=1326652642786390073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.济南市市中区人民医院内科,山东 济南 250000)]), AuthorCompany(id=1326652644426362938, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, xref=2., ext=[AuthorCompanyExt(id=1326652644434751547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652644426362938, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1326652644443140156, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652644426362938, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.06.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.06.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.06.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.06.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1749484800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
系统性红斑狼疮药物治疗进展
谢昕悦 1 , 夏光涛 2 , 刘务斌 1, *
世界临床药物 | 医药专论 2025,46(6): 534-540
收起
收藏切换
世界临床药物 |医药专论 2025 , 46 (6) : 534 -540
系统性红斑狼疮药物治疗进展
全屏
[Author(id=1326652644522831934, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652644615106624, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652644522831934, language=EN, stringName=Xinyue XIE, firstName=Xinyue, middleName=null, lastName=XIE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652644690604097, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652644522831934, language=CN, stringName=谢昕悦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.济南市市中区人民医院内科,山东 济南 250000, bio={"content":"

谢昕悦,主治医师,研究方向:风湿免疫疾病诊治。

"}, bioImg=null, bioContent=

谢昕悦,主治医师,研究方向:风湿免疫疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652642765418551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, xref=1., ext=[AuthorCompanyExt(id=1326652642773807160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China), AuthorCompanyExt(id=1326652642786390073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.济南市市中区人民医院内科,山东 济南 250000)])]), Author(id=1326652644833210435, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326652644921290821, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652644833210435, language=EN, stringName=Guangtao XIA, firstName=Guangtao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652644984205382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652644833210435, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652644426362938, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, xref=2., ext=[AuthorCompanyExt(id=1326652644434751547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652644426362938, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China), AuthorCompanyExt(id=1326652644443140156, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652644426362938, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021)])]), Author(id=1326652645051314248, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326652645118423114, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652645051314248, language=EN, stringName=Wubin LIU, firstName=Wubin, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326652645185531979, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, authorId=1326652645051314248, language=CN, stringName=刘务斌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.济南市市中区人民医院内科,山东 济南 250000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326652642765418551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, xref=1., ext=[AuthorCompanyExt(id=1326652642773807160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China), AuthorCompanyExt(id=1326652642786390073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326652641838477364, companyId=1326652642765418551, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.济南市市中区人民医院内科,山东 济南 250000)])])]
谢昕悦1, 夏光涛2, 刘务斌1, *
作者信息
  • 1.济南市市中区人民医院内科,山东 济南 250000
  • 2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021
通讯作者:
刘务斌,主治医师,研究方向:风湿免疫疾病诊治。
作者简介:

谢昕悦,主治医师,研究方向:风湿免疫疾病诊治。

Advances in drug therapy for systemic lupus erythematosus
Xinyue XIE1, Guangtao XIA2, Wubin LIU1, *
Affiliations
  • 1.Department of Internal Medicine, Shizhong District People's Hospital of Jinan, Jinan 250000, Shandong Province, China
  • 2.Department of Rheumatology and Immunology, Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong Province, China
出版时间: 2025-06-10 doi: 10.13683/j.wph.2025.06.002
文章导航
收藏切换

系统性红斑狼疮(systemic lupus erythematosus,SLE)是一种以多系统受累为特征的慢性自身免疫性疾病,病情反复发作,常伴随感染及器官损伤,威胁患者生存质量。随着分子免疫学研究的突破,SLE的靶向治疗策略取得重要进展。文章基于循证医学证据,系统综述当前SLE药物治疗方案,主要包括传统药物的优化应用,以及创新疗法如贝利尤单抗(belimumab)、泰它西普(telitacicept)等生物制剂和嵌合抗原受体T细胞免疫疗法等新型治疗手段的临床价值,以期为个体化治疗决策提供循证依据。

系统性红斑狼疮  /  药物治疗  /  靶向治疗

Systemic lupus erythematosus(SLE) is is a chronic autoimmune disease characterized by multi-system involvement. The disease recurs repeatedly, often accompanied by infections and organ damage, which seriously threaten the quality of life of patients. With the breakthroughs of molecular immunology research, important progress has been made in the targeted treatment strategies for SLE. Based on evidence-based medical evidence, this paper systematically reviewed current drug treatment regimens for SLE, mainly including the optimized application of traditional drugs, as well as the clinical value of innovative therapies such as biological agents like belimumab and telitacicept, and novel treatment approaches such as chimeric antigen receptor T-cell immunotherapy, in order to provide evidence-based basis for individualized treatment decisions.

systemic lupus erythematosus  /  drug treatment  /  targeted therapy
谢昕悦, 夏光涛, 刘务斌. 系统性红斑狼疮药物治疗进展. 世界临床药物, 2025 , 46 (6) : 534 -540 . DOI: 10.13683/j.wph.2025.06.002
Xinyue XIE, Guangtao XIA, Wubin LIU. Advances in drug therapy for systemic lupus erythematosus[J]. World Clinical Drug, 2025 , 46 (6) : 534 -540 . DOI: 10.13683/j.wph.2025.06.002
  • 山东省自然科学基金(ZR2021MH265)
参考文献 引证文献
排序方式:
[1]
葛均波, 王辰, 王建安. 内科学[M]. 第10版. 北京: 人民卫生出版社, 2024: 820-826.
[2]
梅杨. RSAD2在SLE患者B细胞中异常表达及功能研究[D]. 长沙: 中南大学, 2023.
[3]
尚双双, 李明, 黄传兵. lncRNAs在系统性红斑狼疮中的研究进展[J]. 中国免疫学杂志, 2023, 39(12): 2662-2665.
[4]
苗林, 王清翠, 陈晓华. 组蛋白修饰在系统性红斑狼疮发病机制中作用的研究进展[J]. 中国医药导报, 2023, 20(30):68-71.
[5]
韦安吉, 王春芳. m6 A修饰与调节免疫在系统性红斑狼疮的研究进展[J]. 右江医学, 2023, 51(6): 486-491.
[6]
夏源, 李向培. 微小RNA调控干扰素-α在系统性红斑狼疮发病机制中的作用[J]. 协和医学杂志, 2019, 10(6): 673-678.
[7]
KIRIAKIDOU M, CHING CL. Systemic lupus erythematosus[J]. Ann Intern Med, 2020, 172(11): ITC81-ITC96.
[8]
董霞. 调节性B细胞在自身免疫性皮肤病中的研究进展[J].中国城乡企业卫生, 2024, 39(3): 22-24.
[9]
崔峥, 李鸿斌. 靶向B细胞治疗系统性红斑狼疮研究进展[J]. 内蒙古医科大学学报, 2023, 45(3): 324-328.
[10]
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3):172-185.
[11]
张昕, 赵盛楠, 冯学兵. 中国系统性红斑狼疮的诊治现状及挑战[J]. 诊断学理论与实践, 2024, 23(3): 257-262.
[12]
季兰岚, 张卓莉. 欧洲抗风湿联盟发布系统性红斑狼疮新的管理指南[J]. 中华风湿病学杂志, 2020, 24(7): 500-502.
[13]
黄玉琼, 张亚敏, 陶娟. 糖皮质激素在系统性红斑狼疮中的应用及研究现状[J]. 皮肤科学通报, 2018, 35(3): 296-304.
[14]
王钢. 系统性红斑狼疮长期糖皮质激素维持治疗与器官累积损伤的相关性研究[D]. 合肥: 安徽医科大学, 2017.
[15]
DENG J, CHALHOUB NE, SHERWIN CM, et al.Glucocorticoids pharmacology and their application in the treatment of childhoodonset systemic lupus erythematosus[J].Semin Arthritis Rheum, 2019, 49(2): 251-259.
[16]
柴富, 王春芳. 系统性红斑狼疮相关药物治疗的研究进展[J]. 检验医学与临床, 2022, 19(10): 1423-1427.
[17]
胡曦丹, 王卓. 选择性环氧合酶-2(COX-2)非甾体抗炎药的安全性与有效性[J]. 药学服务与研究, 2016, 16(2): 81-85.
[18]
BINDU S, MAZUMDER S, BANDYOPADHYAY U. Non-steroidal anti-inflammatory drugs(NSAIDs) and organ damage: a current perspective[J]. Biochem Pharmacol, 2020:114147.
[19]
李德鑫, 程振田, 马玉奎. 系统性红斑狼疮治疗药物研究进展[J]. 食品与药品, 2024, 26(4): 405-410.
[20]
王玲玲. 吗替麦考酚酯治疗难治性狼疮性肾炎的临床疗效观察[J]. 航空航天医学杂志, 2022, 33(6): 709-711.
[21]
库丽. 吗替麦考酚酯联合甲泼尼龙对狼疮肾炎患者系统性红斑狼疮疾病活动指数评分及免疫指标的影响[J].山西医药杂志, 2021, 50(7): 1121-1123.
[22]
韩洋, 费文敏, 李可可, 等. 免疫抑制剂的概念和类型[J].皮肤科学通报, 2021, 38(4): 291-297.
[23]
苏利沙, 张根豪, 邓少丽, 等. 常用免疫抑制剂治疗对系统性红斑狼疮患者淋巴细胞亚群的影响[J]. 郑州大学学报(医学版), 2014, 49(2): 236-239.
[24]
王鑫梅, 谢菡. 羟氯喹治疗系统性红斑狼疮的作用机制及疗效研究进展[J]. 山东医药, 2024, 64(26): 111-115.
[25]
GORDON C, AMISSAH-ARTHUR MB, GAYED M, et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults[J].Rheumatology(Oxford), 2018, 57(1): e1-e45.
[26]
FANOURIAKIS A, KOSTOPOULOU M, ANDERSEN J, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update[J]. Ann Rheum Dis, 2024, 83(10): e19.
[27]
钟永芳. 羟氯喹对系统性红斑狼疮患者黄斑区视网膜和脉络膜厚度的影响[D]. 承德: 承德医学院, 2024.
[28]
ZHENG J, GU J, SU Y, et al. Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: results of exploratory subgroup analyses[J]. Mod Rheumato, 202, 33(4): 751-757.
[29]
许蕾, 朱芸, 张昊. 贝利尤单抗治疗系统性红斑狼疮的短期临床观察[J]. 中国医药导报, 2021, 18(31): 96-99.
[30]
郭孟, 陈小三, 蒋玲, 等. 贝利尤单抗对系统性红斑狼疮患者自身抗体浓度的影响[J]. 江苏医药, 2023, 49(3): 300-302.
[31]
唐鹏芳. 贝利尤单抗在系统性红斑狼疮中的疗效及对淋巴细胞VCS参数的影响[J]. 中国医学创新, 2023, 20(11): 10-13.
[32]
张洁. 贝利尤单抗在系统性红斑狼疮患者中的应用效果观察[J]. 实用中西医结合临床, 2024, 24(12): 71-74.
[33]
董瑶. 贝利尤单抗联合羟氯喹与泼尼松治疗系统性红斑狼疮患者的效果[J]. 中国民康医学, 2024, 36(15): 48-51.
[34]
丁琳. 贝利尤单抗治疗难治性狼疮性肾炎的疗效观察及安全性评估[D]. 济南: 山东大学, 2023.
[35]
邹婵娟, 丁菱, 王敏, 等. 贝利尤单抗治疗系统性红斑狼疮合并血栓性微血管病1例并文献复习[J]. 中国医学前沿杂志(电子版), 2023, 15(11): 71-78.
[36]
杨佳, 高洁, 赵文静, 等. 泰它西普在IgA肾病和狼疮性肾炎中的研究进展[J]. 中国现代医学杂志, 2022, 32(19): 51-56.
[37]
SHI F, XUE R, ZHOU X, et al. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease[J]. Immunopharmacol Immunotoxicol, 2021, 43(6): 666-673.
[38]
江文静, 何德宁, 胡建康, 等. 泰它西普治疗中重度活动性系统性红斑狼疮的疗效及全安性观察[J]. 江西医药, 2020,55(11): 1637-1641.
[39]
林千祺, 许夏雨, 邢诒喜, 等. 泰它西普联合标准方案治疗Ⅲ-Ⅴ型活动性狼疮肾炎临床观察[J]. 中国药业, 2023,32(12): 97-100.
[40]
万雨涵, 杨定平. 难治性狼疮性肾炎的治疗方法应用进展[J]. 山东医药, 2024, 64(14): 90-94.
[41]
李浩, 李江涛, 刘丹, 等. 贝利尤单抗和阿尼鲁单抗及泰它西普治疗系统性红斑狼疮疗效和安全性的网状Meta分析[J]. 中国全科医学, 2024: 1-11.
[42]
CROW MK. Type Ⅰ interferon in the pathogenesis of lupus[J]. Ann Rheum Dis, 2023, 82(8): 999-1014.
[43]
RIGGS JM, HANNA RN, RAJAN B, et al. Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist anti body for the treatment of systemic lupus erythematosus[J]. Lupus Sci Med, 2018, 5(1): e000261.
[44]
张培. 注射用贝利尤单抗和阿尼鲁单抗治疗系统性红斑狼疮疗效和安全性的网状meta分析[D]. 石家庄: 河北医科大学, 2023.
[45]
MORAND EF, FURIE R, TANAKA Y, et al. Trial of anifrolumab in active systemic lupus erythematosus[J]. N Engl J Med, 2020, 382(3): 211-221.
[46]
陈晓梅, 吴雪, 罗采南, 等. 系统性红斑狼疮的靶向治疗药物研究进展[J]. 中国新药杂志, 2022, 31(23): 2310-2317.
[47]
张幸国, 林能明, 赵青威, 等. 利妥昔单抗超说明书用药专家共识[J]. 中国现代应用药学, 2024, 41(16): 2298-2310.
[48]
石祥东. 评价小剂量利妥昔单抗治疗系统性红斑狼疮(SLE)的疗效和安全性[J]. 世界复合医学, 2021, 7(1):169-171.
[49]
张玲玲, 魏伟. 治疗自身免疫病药物研究进展[J]. 中国药理学通报, 2019, 35(2): 149-156.
[50]
FANOURIAKIS A, KOSTOPOULOU M, ALUNNO A,et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(6): 736-745.
[51]
龙博泉, 杨岚, 马萍萍, 等. 利妥昔单抗治疗系统性红斑狼疮伴血液危象一例[J]. 中国麻风皮肤病杂志, 2023,39(12): 898-900.
[52]
MOUGIAKAKOS D, KRONKE G, VOLKL S, et al.CD19-targeted CAR T cells in refractory systemic lupus erythematosus[J]. N Engl J Med, 2021, 385(6): 567-569.
[53]
MACKENSEN A, MULLER F, MOUGIAKAKOS D, et al.Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus[J]. Nat Med, 2022, 28(10): 2124-2132.
[54]
MULLER F, TAUBMANN J, BUCCI L, et al. CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up[J]. N Engl J Med, 2024, 390(8): 687-700.
2025年第46卷第6期
48
13
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.06.002
  • 接收时间:2025-01-28
  • 首发时间:2026-11-09
  • 出版时间:2025-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-01-28
基金
山东省自然科学基金(ZR2021MH265)
作者信息
    1.济南市市中区人民医院内科,山东 济南 250000
    2.山东第一医科大学附属省立医院风湿免疫科,山东 济南 250021

通讯作者:

刘务斌,主治医师,研究方向:风湿免疫疾病诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.06.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏